We are capable of storing a virtually infinite amount of visual information in visual long-term memory (VLTM) storage. At the same time, the amount of visual information we can encode and maintain in visual short-term memory (VSTM) at a given time is severely limited. How do these two memory systems interact to accumulate vast amount of VLTM? In this series of experiments, we exploited interindividual and intraindividual differences VSTM capacity to examine the direct involvement of VSTM in determining the encoding rate (or "bandwidth") of VLTM. Here, we found that the amount of visual information encoded into VSTM at a given moment (i.e., VSTM capacity), but neither the maintenance duration nor the test process, predicts the effective encoding "bandwidth" of VLTM.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823324PMC
http://dx.doi.org/10.3758/s13421-019-00954-0DOI Listing

Publication Analysis

Top Keywords

amount visual
12
visual short-term
8
short-term memory
8
visual long-term
8
long-term memory
8
vstm capacity
8
"bandwidth" vltm
8
visual
7
memory
5
vstm
5

Similar Publications

A Comparative Study of the Use of a 980 nm Diode Laser and 10600nm CO2 in the Treatment of Gingival Melanin Pigmentation.

J Lasers Med Sci

December 2024

Department of Periodontics, Dental Implants Research Center, Dental Research Institute, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.

Gingival depigmentation with the help of lasers is known as an effective technique. The aim of this study was to compare the efficiency of 980nm diode and CO2 lasers in the treatment of gingival hyperpigmentation. In this clinical trial study, 14 individuals (8 females and 6 males) with the age range of 19 to 47 years were selected.

View Article and Find Full Text PDF

Femtosecond laser-assisted cataract surgery (FLACS) is a useful technology for anterior segment surgery that creates cleavage planes via photodisruption of ocular tissue. Compared to conventional cataract surgery, FLACS has been thought to potentially improve surgical precision, accuracy, and reproducibility. Its introduction into cataract surgery has enabled the development of new techniques and has been purported to be potentially beneficial in improving surgical safety and providing quicker visual rehabilitation.

View Article and Find Full Text PDF

Purpose: The aim of this study was to investigate the effect of general anesthesia combined with transversus abdominis plane block on postoperative sleep disorders in elderly patients undergoing gastrointestinal tumor surgery.

Methods: For elderly patients with gastrointestinal malignant tumors, we recruited 94 patients, aged 65-80, who were scheduled for radical laparoscopic surgery. Using the random number table method, the patients were randomly divided into two groups, the general anesthesia group (group GA) and the general anesthesia combined with transversus abdominis plane block group (group GT).

View Article and Find Full Text PDF

Background: Global aphasia is a severe communication disorder affecting all language modalities, commonly caused by stroke. Evidence as to whether the functional communication of people with global aphasia (PwGA) can improve after speech and language therapy (SLT) is limited and conflicting. This is partly because cognition, which is relevant to participation in therapy and implicated in successful functional communication, can be severely impaired in global aphasia.

View Article and Find Full Text PDF

Beyond Longer Intervals: Advocating for Regular Treatment of Neovascular AMD.

J Clin Med

December 2024

Division of Ophthalmology, Department of Surgery, UMass Chan-Lahey School of Medicine, Burlington, MA 01805, USA.

Personalizing the management of neovascular age-related macular degeneration (nAMD) poses significant challenges for practicing retina specialists and their patients. This commentary addresses some of these complexities, particularly those that arise in the context of an expanding array of intravitreal agents targeting vascular endothelial growth factor (VEGF) and related retinal disease targets. Many of these newer agents approved by the Food and Drug Administration (FDA) for the treatment of nAMD have labeling that indicates that they can provide non-inferior visual outcomes when compared head-to-head with previously available treatments and can be used at significantly extended dosing intervals in some patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!